We found that in most cases, p16 showed a loss of expression in cartilage and dedifferentiated components, which may suggest that the inhibition of CDK4 and Cyclin D1 was reduced, prompting tumor cells to enter the cell cycle progression. Here, CDK4 is linked to neoplasm.